Geron Corp. buy BiotechBee
Start price
03.03.24
/
70%
€2.10
Target price
31.08.26
€3.70
Performance (%)
73.67%
Price
03.05.24
€3.65
Summary
This prediction is currently active. With a performance of 73.67% the BUY prediction by BiotechBee is a big success. This prediction currently runs until 31.08.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Geron Corp. | 3.081% | 3.081% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
According to BiotechBee what are the pros and cons of Geron Corp. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Geron Corp. diskutieren
Buy mit Kursziel 3,7
Stopped prediction by BiotechBee for Geron Corp.
Geron Corp.
Start price
Target price
Perf. (%)
€2.88
24.06.23
24.06.23
€4.00
30.04.26
30.04.26
-27.18%
03.03.24
03.03.24
Could be very worthwhile Investment >20% year
Geron Corp.
Start price
Target price
Perf. (%)
€2.50
04.01.23
04.01.23
€6.00
31.12.25
31.12.25
38.38%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year